News

Milestone Achieved: Patient Enjoys Year of Seizure Freedom

Milestone Achieved: Patient Enjoys Year of Seizure Freedom

Revolutionary Seizure Management with OneRF® Technology

NeuroOne Medical Technologies Corporation is making waves in the medical technology industry with their innovative OneRF® Ablation System. This groundbreaking device has governed surgical care for patients grappling with neurological disorders, and its capabilities have recently been spotlighted by an inspiring patient story.

Patient Clara's Journey to Seizure Freedom

Clara, a pioneering patient treated with the OneRF® system, recently celebrated a remarkable milestone—she has been seizure-free for over a year. Prior to her treatment, Clara faced the daily challenge of experiencing up to ten seizures. The significant transformation in her life underscores how effective this technology can be.

After undergoing the procedure in June of the previous year, Clara's journey has been nothing short of extraordinary. She is now living a fulfilling life, enjoying new adventures like fishing and pursuing her education full-time.

The Technology Behind OneRF®

The OneRF® Ablation System is unique in the medical field, as it is the first FDA-cleared device to utilize the same stereoelectroencephalography (sEEG) electrode for both diagnostic and treatment purposes. This versatility allows clinicians to conduct monitoring, mapping, and therapeutic ablation all at the patient’s bedside. Many patients treated with the OneRF technology have seen a substantial reduction or even complete freedom from seizures.

Dave Rosa, CEO of NeuroOne, remarked, "This significant milestone validates the purpose and effectiveness of our OneRF® platform. We are excited to expand our technology for other uses, such as the upcoming OneRF® Trigeminal Nerve Ablation System, aimed at treating facial pain. We have submitted a 510(k) application to the FDA for this innovative approach, further demonstrating our commitment to advancing patient care.”

Clara's Reflections on Her Life Post-Treatment

Reflecting on her transformation, Clara shared, "Around this time last year, I was overwhelmed by multiple seizures each day. The treatment has completely changed my life. I can now participate in activities I previously couldn’t, like attending college, enjoying peaceful family dinners, and fishing. I am beyond grateful for the support and care I received." Her positivity serves as a testament to the impact of the OneRF® system.

Dr. Brin Freund, the physician overseeing Clara’s treatment, expressed optimism regarding the OneRF® Ablation System's effectiveness, noting, "Our experience with Clara reinforces the promising outcomes this technology can yield. The potential for further research and clinical applications is vast, and we are optimistic about its future.”

About NeuroOne Medical Technologies Corporation

NeuroOne is dedicated to developing cutting-edge solutions for patients with various neurological disorders. They focus on creating minimally invasive options that enhance the quality of care, including EEG monitoring, drug delivery, and brain stimulation therapies. Their commitment extends beyond epilepsy and encompasses conditions such as Parkinson’s disease, chronic pain, and mood disorders.

For more information about their products and innovations, visit the official NeuroOne website.

Frequently Asked Questions

What is the OneRF® Ablation System?

The OneRF® Ablation System is an advanced medical device that enables both diagnostic and therapeutic procedures using the same electrodes, improving surgical outcomes for patients with epilepsy.

How has Clara's life changed after treatment?

Since her procedure, Clara has been seizure-free and has been able to pursue a full-time college education and engage in recreational activities such as fishing and family outings.

What are the future applications of NeuroOne’s technology?

NeuroOne aims to expand its technology into new treatment areas, including facial pain through the upcoming OneRF® Trigeminal Nerve Ablation System.

What conditions does NeuroOne focus on treating?

The company chiefly targets neurological disorders but is also exploring treatments for conditions such as chronic pain, depression, and mood disorders.

Where can I learn more about NeuroOne’s advancements?

For detailed information, you can visit NeuroOne’s official website to explore their innovations and future projects.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nvidia's Stock Surge: The Hidden Strategy Behind Growth

Updated Category News Views 390

Nvidia's stock surged in 2023 like a rocket ship headed to the moon, making traders sit up and take notice. With its reputation firmly planted in tech innovation, it managed to pull off a jaw-dropping comeback after a sell-off earlier in the year. Resilience Amidst Market Whirlwind This wasn't just any bounce-back; we’re talking about a solid 13% uptick in weeks when...

Continue Reading
Yoshiharu Global Co. Implements 4-for-1 Stock Split Strategy

Updated Category News Views 162

Yoshiharu Global Co. Announces a Significant Stock Split Yoshiharu Global Co. (NASDAQ: YOSH), an innovative restaurant operator specializing in authentic Japanese ramen and rolls, has made an important announcement regarding its stock. The company’s Board of Directors has authorized a 4-for-1 forward stock split to enhance shareholder engagement and market activity....

Continue Reading
Viatris Unveils Tender Offer Pricing for Senior Notes

Updated Category News Views 52

Viatris Sets Pricing for Senior Notes Tender Offers Viatris Inc. (NASDAQ: VTRS) is moving ahead with cash tender offers for certain senior notes and has announced the pricing terms. The effort is part of a broader plan to streamline outstanding debt and sharpen the company’s financial profile. In practical terms, Viatris is offering to buy back targeted notes for cash...

Continue Reading
AB Akola Group Aims for Growth in Feed Production Capacity

Updated Category News Views 259

AB Akola Group's Ambitious Expansion Plans AB Akola Group, one of the prominent agricultural and food production organizations in the Baltic region, is gearing up for an exciting chapter of growth and innovation. With ownership of the well-known company Kauno Gr?dai, the group is focusing on enhancing its production capabilities to remain competitive in the market. A...

Continue Reading
Global Paraxylene Demand to Surge by 2034, Insights Revealed

Updated Category News Views 142

A Surge in Paraxylene Demand Ahead The global market for paraxylene, a crucial compound in the production of polyester fibers and PET resin, is witnessing significant growth. Market analysts predict that the volume could reach a staggering 96.40 million tons by 2034, marking a steady growth rate of 4.59% annually from the year 2025 onwards. The driving forces behind this...

Continue Reading